0001209191-21-020478.txt : 20210315 0001209191-21-020478.hdr.sgml : 20210315 20210315164126 ACCESSION NUMBER: 0001209191-21-020478 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210312 FILED AS OF DATE: 20210315 DATE AS OF CHANGE: 20210315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PIMSTONE SIMON N. CENTRAL INDEX KEY: 0001620084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 21742038 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G4W8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-12 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001620084 PIMSTONE SIMON N. 200 - 3650 GILMORE WAY BURNABY A1 V5G 4W8 BRITISH COLUMBIA, CANADA 1 1 0 0 CEO Stock Option (Right to Buy) 20.55 2021-03-12 4 A 0 225000 0.00 A 2031-03-11 Common Shares 225000 225000 D Vesting 25% on January 1, 2022 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. /s/ Cassandra Robinson, Attorney-in-fact 2021-03-15